Recorded Chinese product: 单唾液酸四己糖神经节苷脂钠注射液单唾液酸四己糖神经节苷脂钠注射液
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 北京赛升药业股份有限公司Chinese legal name: 北京赛升药业股份有限公司
主要成分Active Ingredients
- 单唾液酸四己糖神经节苷脂钠Dantuo Yesuan Siji Tangshen Jingjie Ganzhi Na
药物知识说明
单唾液酸四己糖神经节苷脂钠是一种在国家药监局注册认定的药品。该药品含有单唾液酸四己糖神经节苷脂钠-2793b17a等成分。
该药品关联的活性成分包括：单唾液酸四己糖神经节苷脂钠Dantuo Yesuan Siji Tangshen Jingjie Ganzhi Na。这些成分信息来自国家药监局数据库。
该药品标注的生产企业为：北京赛升药业股份有限公司Chinese legal name: 北京赛升药业股份有限公司。
您可以探索含有相同成分的其他药品：单唾液酸四己糖神经节苷脂钠-2793b17a成分药品。
本页面内容来自国家药监局数据库，MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 单唾液酸四己糖神经节苷脂钠注射液) is a medicine registered with the national drug regulatory authority. It contains recorded ingredients as active ingredient(s).
Active ingredients associated with this product: 单唾液酸四己糖神经节苷脂钠Dantuo Yesuan Siji Tangshen Jingjie Ganzhi Na.
Manufacturers recorded for this product: 北京赛升药业股份有限公司Chinese legal name: 北京赛升药业股份有限公司.
Explore other medicines containing the same ingredient: 单唾液酸四己糖神经节苷脂钠 productsProducts containing this recorded ingredient.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 单唾液酸四己糖神经节苷脂钠注射液Recorded Chinese product: 单唾液酸四己糖神经节苷脂钠注射液
- 剂型Dosage form: 注射剂Injection
- 规格Specification: 2ml*6支2 mL × 6 units
本段仅展示注册/说明书已记录的身份属性，不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
主要成分Ingredients
生产企业Manufacturer
- 北京赛升药业股份有限公司Chinese legal name: 北京赛升药业股份有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20093980
关联实体Relationships
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录（非改写、非AI摘要），非正式英文标签，亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20093980
Manufacturer
Chinese legal name: 北京赛升药业股份有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
2 mL × 6 units
中文说明书原文Original Chinese source label
批准文号
国药准字H20093980
生产企业
北京赛升药业股份有限公司(国产)
适应症
用于治疗血管性或外伤性中枢神经系统损伤；帕金森病。
用法用量
每日20-40mg，遵医嘱一次或分次肌注或缓慢静脉滴注。在病变急性期(尤急性创伤)：每日100mg，静脉滴注，2-3周后改为维持量，每日20-40mg，一般6周。对帕金森氏病，首剂量500-1000mg，静脉滴注，第二日起每日200mg，皮下、肌注或静脉滴注，一般用至18周。
不良反应
少数病人用本品后出现皮疹反应，应建议停用。
禁忌
已证实对本品过敏；遗传性糖脂代谢异常（神经节苷脂累积病，如：家族性黑蒙性痴呆、视网膜变性病）。
注意事项
使用本品前，请仔细阅读药品说明书；应遵医嘱使用。
贮藏
密闭室温保存。
规格
2ml*6支
信息来源Source and scope
国家药品监督管理局（中国）药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围：当前 MedicineGraph 注册记录及已记录的精确关系；非完整目录，亦不构成疗效等同主张，也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.